News

Reed's Emerges Stronger with 2024 Financial Results Unveiled

Reed's Emerges Stronger with 2024 Financial Results Unveiled

2024 Financial Performance Overview

Reed’s, Inc. (OTCQX: REED), a prominent name in the natural beverages sector, has unveiled its financial results for the fourth quarter and full year of 2024. The company, recognized for its handcrafted ginger beverages, is dedicated to enhancing its operational efficiency and profitability. During the fourth quarter, Reed’s recorded net sales of $9.7 million, although this reflects a decrease from $11.7 million in the same period the previous year.

Fourth Quarter Highlights

The fourth quarter figures highlight some noteworthy developments:

  • Gross profit surged significantly to $2.9 million, escalating from $0.5 million, yielding a gross margin of 30% compared to 4% last year. This change is attributable to the elimination of one-time charges/fees from the prior year.
  • Operational costs saw improvements, with delivery and handling expenses reduced by 10%, resulting in a cost of $3.00 per case.
  • Despite a rise in selling, general, and administrative expenses to $4.1 million, Reed’s operating loss improved significantly to $2.9 million versus $5.0 million in the previous year.
  • Modified EBITDA showed a promising shift, recorded at $(0.7) million compared to a gain of $43,000 in Q4 of 2023.

Full Year Financial Performance Analysis

For the entire year of 2024, Reed’s reported net sales of $37.9 million, down from $44.7 million the previous year. However, gross profit increased by 18% to $11.4 million, bolstered by an improved gross margin to 30% from 21.7%.

Improved Balance Sheet Strategies

Throughout 2024, Reed’s has been actively working to strengthen its balance sheet. The company successfully closed a $10 million private placement, along with securing new financing options that allow for strategic investment in inventory, marketing, and expansion.

  • Total debt was significantly reduced to $9.6 million, down from $27.4 million the previous year.
  • Cash reserves increased to approximately $10.4 million, allowing additional leverage for operational activities.

Norman E. Snyder, Jr., CEO of Reed’s, expressed optimism regarding the company’s trajectory, stating, "We're excited about the meaningful progress we've made in our operational efficiencies and overall financial footing. Our increased retail penetration places us in a promising position for growth across various platforms like Kroger, Costco, and Albertsons/Safeway, allowing us to establish a more robust market presence."

Strategic Leadership Moves

Further bolstering its operational capacity, Reed's welcomed new executives: Douglas W. McCurdy as CFO, and Salvatore Vassallo as VP of Operations. Both leaders bring extensive experience in finance and supply chain dynamics, which are anticipated to help refine efficiency and scalability within the company.

Product Line Expansion and Future Outlook

As Reed’s sets its sights on 2025, the company aims to build on its momentum by launching a new line of multifunctional beverages expected to debut soon. With over 8,000 points of distribution secured across key retailers nationwide, Reed’s is in a prime position to capture new market segments while addressing customer health consciousness with its innovative offerings.

The developments and strategic financial decisions made in 2024 position Reed’s Inc. favorably for a stronger future, opening doors for profitability and growth in the beverage sector.

Frequently Asked Questions

1. What were Reed’s net sales for Q4 2024?

Reed's net sales for Q4 2024 were $9.7 million, down from $11.7 million in Q4 2023.

2. How did gross profit change in 2024?

Gross profit in 2024 increased to $11.4 million, an 18% improvement from 2023.

3. Who has joined Reed's management team recently?

Douglas W. McCurdy has been appointed as CFO, and Salvatore Vassallo as VP of Operations.

4. What are Reed’s future product plans?

The company is set to launch a new multi-functional beverage line expected to enhance their product portfolio.

5. How is Reed's addressing operational costs?

Reed's has successfully reduced delivery and handling expenses, improving operational efficiency significantly.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 6

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 5

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 3

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 8

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 9

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 6

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 3

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 9

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 3

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Storelocal Storage Helps Hurricane Victims with Free Storage

Updated Category News Views 45

Storelocal Storage's Generous Offer to Hurricane Victims Storelocal Storage has initiated a compassionate program supporting victims of Hurricane Helene by offering two months of complimentary self-storage at its facilities. This initiative focuses on aiding individuals and families who are navigating the challenging process of rebuilding their lives after the recent...

Continue Reading
Investigation into DocGo Inc. Focuses on False Statements

Updated Category News Views 261

Investigation into DocGo Inc.'s Possible Misconduct Schubert Jonckheer & Kolbe LLP is currently conducting an investigation regarding potential legal claims against DocGo Inc. (NASDAQ: DCGO) in light of allegations involving false statements. These claims particularly concern the educational background of DocGo's former CEO and assertions made about the company's market...

Continue Reading
Amplify Energy's Strategic Acquisition of Juniper Capital Assets

Updated Category News Views 132

Amplify Energy’s Strategic Move to Acquire Juniper Capital's Assets Today, Amplify Energy Corp. (NYSE: AMPY) has shared an exciting update regarding its decision to acquire the upstream Rocky Mountain portfolio of Juniper Capital. This acquisition is not just a merger; it's a vital step in Amplify's mission to bolster its portfolio and future growth prospects. Unpacking...

Continue Reading
Discover the Inspiring Journey of ''Sunshine in My Heart''

Updated Category News Views 112

Introducing ''Sunshine in My Heart'' Xulon Press proudly presents the first volume of My Sun & Shade book series, an empowering narrative aimed at women, chronicling profound moments of personal growth and spiritual enlightenment. A Journey of Faith and Resilience Written by Angela M. Viola, this memoir invites readers into a deeply personal story that unfolds the themes...

Continue Reading
Civitas Resources Adjustments: KeyBanc's Insights and Outlook

Updated Category News Views 57

KeyBanc Adjusts Price Target for Civitas Resources KeyBanc Capital Markets has recently updated its price target for Civitas Resources (NYSE:CIVI), a company known for its oil and gas production activities, reducing it from $94.00 to $84.00. This revision reflects current investor concerns regarding the company's projected oil production for 2025, mainly due to a...

Continue Reading